Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
ID07163975

Success of Complete Pulpotomy and Root Canal Treatment and Quality of Life in Patients With Symptomatic Irreversible Pulpitis With Type 2 Diabetes Mellitus: A Randomized Clinical Trial

Led by Postgraduate Institute of Dental Sciences Rohtak · Updated on 2025-09-09

106

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating the effects of type 2 diabetes mellitus (T2DM) on teeth with irreversible pulpitis, a painful dental condition. This study compares two dental treatments: complete pulpotomy and root canal therapy, in patients with T2DM. The aim is to understand which treatment has better success in managing irreversible pulpitis in mature permanent mandibular posterior teeth, as limited prior research has focused on diabetic patients with this condition. The study involves two treatment groups: one receiving complete pulpotomy and the other undergoing root canal treatment. Complete pulpotomy involves removing the exposed pulp tissue, controlling bleeding, and placing a biologically active material to promote healing, followed by restoration. Root canal treatment is performed in a single visit with cleaning, shaping, and filling of the root canals using standard dental instruments and irrigation. Both treatments are evaluated over a one-year period. Participants will be monitored through clinical and radiographic examinations at 3, 6, and 12 months to assess treatment success. Quality of life will also be assessed at 1 week, 6 months, and 12 months post-treatment. The study tracks healing, tooth vitality, and patient well-being related to dental health. The total study duration for each participant is one year, with close follow-up to evaluate outcomes and safety.

CONDITIONS

Brief Title

Complete Pulpotomy and Root Canal Treatment Patients With Irreversible Pulpitis With Type 2 Diabetes Mellitus

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with type 2 diabetes mellitus defined by HbA1c 6.5% - 8%, fasting plasma glucose 26;126 mg/dL, 2-hour plasma glucose 26;200 mg/dL during OGTT, or random plasma glucose 200 mg/dL with symptoms
  • Age between 18 and 70 years
  • Permanent mandibular posterior teeth with clinical and radiographic signs of irreversible pulpitis (PAI score 2)
  • Tooth responds positively to pulp sensibility test and has no tenderness on percussion
  • Body mass index (BMI) less than 30 kg/m2
Not Eligible

You will not qualify if you...

  • Patients with immunocompromised diseases or chronic kidney disease
  • Smokers, pregnant or lactating women
  • Teeth with immature roots or retained deciduous teeth
  • Bleeding that cannot be controlled within 5 minutes
  • Teeth with signs or symptoms of apical periodontitis
  • Teeth with procedural errors, cracks, or fractures
  • Teeth with probing depth greater than 4 mm
  • Recent antibiotic use in past 1 month or requiring antibiotic prophylaxis, and analgesic use in past 3 days
  • Patients taking drugs affecting bone metabolism such as immune-suppressants, SSRIs, bisphosphonates, or hormone replacement therapy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Single visit for treatment

Participants receive either complete pulpotomy or root canal treatment for irreversible pulpitis in mandibular permanent posterior teeth.

1 treatment visit (in-person)

Follow-up

Duration - 12 months

Participants are monitored for clinical and radiographic success and quality of life after treatment.

Visits at 1 week, 3 months, 6 months, and 12 months post treatment

Trial Site Locations

Total: 1 location

1

PGIDS Rohtak

Rohtak, Haryana, India, 124001

Actively Recruiting

Loading map...

Research Team

J

Jigyasa Duhan, MDS

A

Anmol Jain

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Phase 1b Study of QX1206 in Type 2 Diabetes Mellitus Patie...

Type 2 Diabetes Mellitus (T2DM)

Actively Recruiting

1 location

A Phase 3, Randomized, Open-Label Trial Comparing Efficacy a...

Type 2 Diabetes Mellitus (T2DM)

Actively Recruiting

1 location

A Randomized, Double-blind, Placebo-Controlled Trial Compari...

Type 2 Diabetes Mellitus (T2DM)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here